Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond–Blackfan anaemia
- 1 January 2000
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 108 (1) , 167-175
- https://doi.org/10.1046/j.1365-2141.2000.01796.x
Abstract
Diamond–Blackfan anaemia (DBA) is a constitutional pure red cell aplasia presenting in early childhood. In some patients, neutropenia and/or thrombocytopenia have also been observed during the course of the disease. We have followed 28 patients with steroid-refractory DBA for up to 13 years with serial peripheral blood counts and bone marrow (BM) aspirates and biopsies. In 21/28 (75%) patients, moderate to severe generalized BM hypoplasia developed, with overall cellularities ranging from 0% to 30%. Marrow hypoplasia correlated with the development of neutropenia (9/21; 43%) and/or thrombocytopenia (6/21; 29%) in many patients. No patient had either cytogenetic abnormalities or progressed to acute leukaemia, although one 13-year-old developed marked marrow fibrosis and trilineage dysplasia. We used the in vitro long-term culture-initiating cell (LTC-IC) assay to quantify multilineage, primitive haematopoietic progenitors in a representative subset of these patients. LTC-IC assays showed equivalent frequencies of cobblestone area-forming cells (CAFCs) with a mean of 5·42/105 cells ± 1·9 SD and 6·13/105 cells ± 2·6 SD in nine patients and six normal controls respectively. The average clonogenic cell output per LTC-IC, however, was significantly lower in DBA patients (mean 2·16 ± 1·2 SD vs. 7·36 ± 2·7 SD in normal controls, P = 0·0008). Our results suggest that the underlying defect in patients with severe refractory DBA may not be limited to the erythroid lineage, as was evidenced by the development of pancytopenia, bone marrow hypoplasia and reduced clonogenic cell output in LTC-IC assays.Keywords
This publication has 32 references indexed in Scilit:
- Pediatric Bone Marrow CellularityJournal of Pediatric Hematology/Oncology, 1998
- Diamond-Blackfan anaemia: genetic homogeneity for a gene on chromosome 19q13 restricted to 1.8 MbNature Genetics, 1997
- Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adultsBritish Journal of Haematology, 1996
- In vitro progenitor analysis in a Diamond Blackfan anaemia patient who responded once but not twice to interleukin‐3 therapy, using short‐term and long‐term cultures and c‐kit analysisBritish Journal of Haematology, 1996
- Diamond-Blackfan Anemia Natural History and Sequelae of TreatmentMedicine, 1996
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- Age‐related alterations in erythroid and granulopoietic progenitors in Diamond‐Blackfan anaemiaBritish Journal of Haematology, 1994
- Treatment of Diamond‐Blackfan anaemia with haematopoietic growth factors, granulocyte‐macrophage colony stimulating factor and interleukin 3: sustained remissions following IL‐3British Journal of Haematology, 1991
- Diamond-Blackfan syndrome and neutropenia.Journal of Clinical Pathology, 1991
- T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia.Journal of Clinical Investigation, 1982